Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Up-front red blood cell transfusion followed by maintenance epoetin alfa during chemotherapy in anemic patients with breast, colorectal, or ovarian cancer
ISRCTN81146641Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epoetin alfa in cancer-associated anemia (CRA), breast cancer, colorectal cancer (CRC) and 1 more, sponsored by Leiden University Medical Center. Primary endpoints: Hemoglobin levels before the start of and during chemotherapy and Safety of the pCATS anemia treatment regimen. Started Sep 2005; status: completed.
02
Drugs
epoetin alfa
03
Conditions
cancer-associated anemia (CRA)breast cancercolorectal cancer (CRC)ovarian cancer
Beyond the preview
Go deeper on ISRCTN81146641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81146641.